Does NELFINAVIR Cause Lipodystrophy acquired? 112 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Lipodystrophy acquired have been filed in association with NELFINAVIR (VIRACEPT). This represents 9.6% of all adverse event reports for NELFINAVIR.
112
Reports of Lipodystrophy acquired with NELFINAVIR
9.6%
of all NELFINAVIR reports
1
Deaths
1
Hospitalizations
How Dangerous Is Lipodystrophy acquired From NELFINAVIR?
Of the 112 reports, 1 (0.9%) resulted in death, 1 (0.9%) required hospitalization.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELFINAVIR. However, 112 reports have been filed with the FAERS database.
What Other Side Effects Does NELFINAVIR Cause?
Foetal exposure during pregnancy (290)
Drug resistance (117)
Virologic failure (111)
Viral mutation identified (104)
Eyelid ptosis (88)
Pathogen resistance (87)
Mitochondrial toxicity (86)
Diplopia (83)
Progressive external ophthalmoplegia (73)
Treatment failure (69)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which NELFINAVIR Alternatives Have Lower Lipodystrophy acquired Risk?
NELFINAVIR vs NELVUTAMIG
NELFINAVIR vs NEMOLIZUMAB
NELFINAVIR vs NEMOLIZUMAB-ILTO
NELFINAVIR vs NEOMYCIN
NELFINAVIR vs NEORAL